Publication: 99m-Tc-MDP-scintimammography in the evaluation of breast masses or tumor angiogenesis
| dc.contributor.authors | Turhal, NS; Dane, F; Dede, F; Gumus, M; Yumuk, PF; Cakalagaoglu, F; Savci, D; Karaman, M; Gulluoglu, B; Turoglu, HT | |
| dc.date.accessioned | 2022-03-12T17:16:18Z | |
| dc.date.accessioned | 2026-01-11T10:26:55Z | |
| dc.date.available | 2022-03-12T17:16:18Z | |
| dc.date.issued | 2004 | |
| dc.description.abstract | Background: Vascular endothelial growth factor (VEGF) is a prognostic factor in breast cancer. One of the mechanisms of extra-skeletal uptake of Tc-99m-methylenediphosphonate (MDP) is suggested to be tumor vascularity. We studied the correlation between MDP uptake and VEGF and compared the diagnostic accuracy of mammography versus MDP-scintimammography(MDP-S). Materials and Methods: Fifty-four patients with suspicion of breast cancer were evaluated. Breast images were collected 5-10 minutes after injection of Tc-99m-MDP prior to biopsy. Tissue slides were stained using a rabbit-polyclonal anti-VEGE Results: MDP-S showed a diagnostic accuracy of 83.3% in BIRADS category 4 lesions. Four out of 23 benign lesions were false-positive. The tumor to background (TM/BG) ratio of early images of MDP-S was correlated with VEGF staining (p: 0.014) and with tumor size (p: 0.006). Conclusion: Early images of Tc-99m-MDP-S may satisfactorily identify cancers with increased neovascularization. MDP-S seems to be an accurate imaging modality, especially in BIRADS category 4 lesions. | |
| dc.identifier.doi | doiWOS:000222757000029 | |
| dc.identifier.eissn | 1791-7530 | |
| dc.identifier.issn | 0250-7005 | |
| dc.identifier.pubmed | 15274391 | |
| dc.identifier.uri | https://hdl.handle.net/11424/227509 | |
| dc.identifier.wos | WOS:000222757000029 | |
| dc.language.iso | eng | |
| dc.publisher | INT INST ANTICANCER RESEARCH | |
| dc.relation.ispartof | ANTICANCER RESEARCH | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | breast cancer | |
| dc.subject | mammography | |
| dc.subject | technetium Tc-99m-medronate | |
| dc.subject | VEGF | |
| dc.subject | ENDOTHELIAL GROWTH-FACTOR | |
| dc.subject | POSITIVE PREDICTIVE-VALUE | |
| dc.subject | TC-99M METHOXYISOBUTYLISONITRILE | |
| dc.subject | MAMMOGRAPHIC FEATURES | |
| dc.subject | CANCER | |
| dc.subject | SCINTIMAMMOGRAPHY | |
| dc.subject | TC-99M-SESTAMIBI | |
| dc.subject | SCINTIGRAPHY | |
| dc.subject | MECHANISMS | |
| dc.subject | CARCINOMA | |
| dc.title | 99m-Tc-MDP-scintimammography in the evaluation of breast masses or tumor angiogenesis | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 2006 | |
| oaire.citation.issue | 3B | |
| oaire.citation.startPage | 1999 | |
| oaire.citation.title | ANTICANCER RESEARCH | |
| oaire.citation.volume | 24 |
